Tailored COVID-19 Testing Support Plan for Francophone African Born Immigrants

NCT ID: NCT05805163

Last Updated: 2023-04-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-30

Study Completion Date

2024-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to test the effectiveness of a culturally sensitive COVID-19 testing intervention designed for Francophone (French speaking) African Born Immigrants (FABI) . The main question this study aims to answer is whether or not a a culturally sensitive COVID-19 educational pamphlet added to the home-based test will improve testing rates compared to receiving a standard home-based test alone.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Upon consenting, all participants will receive basic COVID-19 testing instructions from trained bilingual/bicultural Francophone African Born Immigrant (FABI) Community Health Workers (CHW's). Next, participants will be randomly assigned to either the control or intervention study arms. In the control condition (n=50) participants will receive a standard COVID-19 home-based test kit. In contrast, those assigned to the intervention condition (n=50) will receive the same COVID-19 home-based test kit plus a FABI culturally sensitive COVID-19 educational pamphlet. Lastly, (n=10) participants from each arm will be randomly selected to participate in qualitative interviews to assess their experiences with CHWs and their test kit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID19 Testing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Participants will be mailed a standard COVID-19 home-based test kit.

Group Type ACTIVE_COMPARATOR

Standard COVID-19 home-based test kit

Intervention Type BEHAVIORAL

Standard COVID-19 home-based test kit

Intervention

Participants will be mailed a standard COVID-19 home-based test plus the FABI culturally sensitive COVID-19 educational pamphlet.

Group Type EXPERIMENTAL

FABI tailored COVID-19 testing pamphlet

Intervention Type BEHAVIORAL

FABI adapted COVID-19 educational pamphlet

Standard COVID-19 home-based test kit

Intervention Type BEHAVIORAL

Standard COVID-19 home-based test kit

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FABI tailored COVID-19 testing pamphlet

FABI adapted COVID-19 educational pamphlet

Intervention Type BEHAVIORAL

Standard COVID-19 home-based test kit

Standard COVID-19 home-based test kit

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

Texas Woman's University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R0704

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

FY2023-241

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

SEARCH SAPPHIRE Phase B
NCT05768763 RECRUITING NA
Home-based AIDS Care Project
NCT00119093 TERMINATED NA